Latest return on equity
Alnylam Pharmaceuticals Return on equity
Direct answer
Alnylam Pharmaceuticals's return on equity is 96.56%.
The verified market snapshot reports 96.56%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 18, 2026.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 96.56%
Explore related company data
View Alnylam Pharmaceuticals's market capitalizationView Alnylam Pharmaceuticals's p/e ratioView Alnylam Pharmaceuticals's price-to-book ratioView Alnylam Pharmaceuticals's 52-week price rangeView Alnylam Pharmaceuticals's revenue growthView Alnylam Pharmaceuticals's profit marginView Alnylam Pharmaceuticals's debt-to-equity ratioView all Alnylam Pharmaceuticals key metricsReturn to Alnylam Pharmaceuticals profile